Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $26.07 USD
Change Today -0.07 / -0.27%
Volume 0.0
STERLINBIO On Other Exchanges
STERLINBIO is not on other exchanges.
As of 9:29 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

sterling biotech ltd (STERLINBIO) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/15 - $27.14
52 Week Low
10/13/14 - $23.07
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sterling biotech ltd (STERLINBIO) Related Businessweek News

No Related Businessweek News Found

sterling biotech ltd (STERLINBIO) Details

Sterling Biotech Limited manufactures and sells pharma grade gelatin and di-calcium phosphate, and other pharma products in India. It offers gelatin from animal bones primarily for the pharmaceuticals and food industry. The company also offers anti-cancer products, including DOXO Rubicin and IDARUBICIN, which are anti-cancer chemotherapy drugs; Daunorubicin for treating acute lymphocytic and myelocyticleukemias; IMATINIB, a drug used to treat cancers; and EPI Rubicin, an anthracycline drug used for chemotherapy. In addition, it provides Lovastatin, a cholesterol-lowering agent that belongs to the class of medications called statins; DACARBAZINE, which is used to treat Hodgkin disease and malignant melanoma; Temozolamide, an oral alkylating agent used for the treatment of Grade IV astrocytoma; and Simvastatin, a lipid lowering drug used to decrease heart problems in those at a high risk. Sterling Biotech Limited was incorporated in 1985 and is based in Atladra, India.

877 Employees
Last Reported Date: 06/10/15
Founded in 1985

sterling biotech ltd (STERLINBIO) Top Compensated Officers

Joing Managing Director and Executive Directo...
Total Annual Compensation: 2.4M
Chairman, Managing Director and Chief Financi...
Total Annual Compensation: 1.2M
Compensation as of Fiscal Year 2014.

sterling biotech ltd (STERLINBIO) Key Developments

Sterling Biotech Limited, Annual General Meeting, Jun 30, 2015

Sterling Biotech Limited, Annual General Meeting, Jun 30, 2015.

Sterling Biotech Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended March 31, 2015

Sterling Biotech Limited announced unaudited standalone earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales/income from operations was INR 1,006.299 million against INR 1,882.136 million a year ago. Loss from operations before other income and finance costs was INR 573.420 million against INR 271.486 million a year ago. Loss from ordinary activities after finance costs but before tax was INR 1,337.356 million against INR 1,529.596 million a year ago. Net loss was INR 903.456 million against INR 1,033.296 million a year ago. Diluted loss per share before and after extraordinary items was INR 2.09 against INR 2.39 a year ago.

Sterling Biotech Limited, Board Meeting, May 15, 2015

Sterling Biotech Limited, Board Meeting, May 15, 2015. Agenda: To consider quarterly results.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLT:IN 6.40 INR +0.15

STERLINBIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for STERLINBIO.
View Industry Companies

Industry Analysis


Industry Average

Valuation STERLINBIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STERLING BIOTECH LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at